Kenneth Dahl

11PUBLICATIONS
8CO-AUTHORS
Sensor technology (incl. chemical aspects)Bioprocessing, bioproduction and bioproductsAutonomic nervous systemInstruments and techniquesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 26, 2025
Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [11C]AZD2423.

Kenneth Dahl, Peter Johnström, Miklós Tóth

|Aug 31, 2022
Good manufacturing procedure production of [18 F]SynVesT-1, a radioligand for in vivo positron emission tomography imaging of synaptic vesicle glycoprotein 2A.

Kenneth Dahl, Stefan Larsson, Peter Bonn

|Jul 08, 2022
Synthesis and Preclinical Evaluation of [11C]AZ11895530 for PET Imaging of the Serotonin 1A Receptor.

Kenneth Dahl, Peter Johnström, Anton Forsberg-Morén

|May 29, 2021
Fully automated production of the fibroblast activation protein radiotracer [18 F]FAPI-74.

Kenneth Dahl, Emma Jussing, Lovisa Bylund

|Jul 30, 2020
Radiosynthesis of a Bruton's tyrosine kinase inhibitor, [11 C]Tolebrutinib, via palladium-NiXantphos-mediated carbonylation.

Kenneth Dahl, Timothy Turner, Neil Vasdev

|May 21, 2020
Synthesis, in vitro and in vivo evaluation of 11C-O-methylated arylpiperazines as potential serotonin 1A (5-HT1A) receptor antagonist radiotracers.

Vidya Narayanaswami, Junchao Tong, Ferdinando Fiorino

Pageof 2